Overview
Mikko Liukkonen practices practicing medicine in Kuopio, Finland.
Liukkonen is highly rated in 2 conditions, according to our data. Their clinical expertise encompasses Age-Related Macular Degeneration (ARMD) and Late-Onset Retinal Degeneration.
They are actively involved in clinical research, co-authoring 25 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Mikko K. Liukkonen
Is Mikko K. Liukkonen a top-rated expert for Age-Related Macular Degeneration (ARMD)?
MediFind is an objective health platform that identifies experts based on real-world data. Mikko K. Liukkonen is classified as an Advanced expert for Age-Related Macular Degeneration (ARMD), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Mikko K. Liukkonen participate in research or clinical trials?
Yes. Mikko K. Liukkonen has published 25 articles and abstracts on conditions like Age-Related Macular Degeneration (ARMD). You can view a list of Mikko K. Liukkonen's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Age-Related Macular Degeneration (ARMD)
- Late-Onset Retinal DegenerationLiukkonen isAdvanced. Learn about Late-Onset Retinal Degeneration.